Looking back at treatments for psoriasis and other inflammatory skin diseases
Reviews past treatment records in psoriasis and other inflammatory skin diseases.
Plain-language title generated from the registry record
Registry title: LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
Key facts
- Where
- Rozzano, ItalySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study looks at existing records of people aged 12 and older with psoriasis, atopic dermatitis, vitiligo, alopecia areata or hidradenitis suppurativa treated at Italian centers.
- Age
- 12 years or older at the first recorded visit.
- Sex
- All sexes can join.
- Disease stage
- A documented diagnosis of psoriasis, atopic dermatitis, vitiligo, alopecia areata or hidradenitis suppurativa.
- Earlier treatment
- The person can have systemic therapies or be treated with them.
Main reasons for not taking part
- Opt-out exercised
- Medical records with insufficient data
Read by machine on 12 November 2026.
Where in Italy
- IRCCS Istituto Clinico Humanitas - Dermatology UnitRozzano, ItalyContact: Antonio Costanzo, MDNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fondazione ISIDE
- Trial code
- NCT07336641
- Record updated
- 15 January 2026
- Original description
This multicenter retrospective observational registry study will collect existing clinical data from Italian centers to describe epidemiology, treatment patterns, clinical evolution, safety, and comorbidities in patients aged 12 years and older with psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.Read full original descriptionShow less
LANDSCAPE - Demographic Characteristics and Treatment Profiles of Patients Affected by Inflammatory Skin Diseases (Psoriasis, Atopic Dermatitis, Alopecia Areata, Vitiligo, Hidradenitis Suppurativa) in Italian Clinical Practice
This multicenter retrospective observational registry study will collect existing clinical data from Italian centers to describe epidemiology, treatment patterns, clinical evolution, safety, and comorbidities in patients aged 12 years and older with psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.
Inclusion: Documented diagnosis of psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa; Age 12 years or older at the first recorded visit; Eligible for or treated with systemic therapies; At least one documented visit during January 2016 to December 2025; No opt-out exercised.
Exclusion: Opt-out exercised; Medical records with insufficient data.